Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 31;47(3):e20200096.
doi: 10.36416/1806-3756/e20200096. eCollection 2021.

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases

[Article in English, Portuguese]
Affiliations

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases

[Article in English, Portuguese]
Pedro Paulo Teixeira E Silva Torres et al. J Bras Pneumol. .

Abstract

Many conditions result in chronic interstitial lung disease (ILD), being classified as fibrosing ILDs, including idiopathic pulmonary fibrosis, connective tissue diseases, sarcoidosis, and fibrotic hypersensitivity pneumonitis. HRCT plays an important role in the clinical evaluation of fibrosing ILDs. Current treatment perspectives are encouraging and reinforce the need for HRCT scans of adequate technical quality for early detection of fibrosing ILD. Despite efforts in this regard, the significance and management of imaging findings of early interstitial lung abnormalities have yet to be clarified. After identification of CT findings consistent with fibrosing ILD, radiologists must be able to identify characteristic morphological patterns and, in some cases, features of specific clinical entities. In cases in which HRCT features are not sufficiently specific for a definitive diagnosis, HRCT can aid in selecting the best site for surgical lung biopsy. CT follow-up is useful for identifying progressive fibrosing ILDs and detecting complications unrelated to the underlying disease, including infections, acute exacerbations, and neoplasms. Automated quantification tools have clinical applicability and are likely to be available for use in imaging analysis in the near future. In addition, incorporation of CT evaluation into scoring systems based on clinical and functional parameters for staging fibrosing disease is likely to become valuable in determining prognosis. Knowledge of the clinical applications of CT evaluation is essential for specialists managing patients with fibrosing ILD and can have a positive impact on the clinical course of the disease.

Inúmeras doenças determinam dano intersticial crônico no parênquima pulmonar e são agrupadas com a denominação de pneumopatias intersticiais fibrosantes, incluindo fibrose pulmonar idiopática, doenças do colágeno, sarcoidose, pneumonite por hipersensibilidade fibrótica etc. Entre os métodos complementares à avaliação clínica, a TCAR tem um papel relevante. Perspectivas atuais de tratamento são encorajadoras e reforçam a necessidade de realização de estudos com técnica adequada, visando a detecção confiável de acometimento intersticial fibrosante o mais precocemente possível. Embora esforços tenham sido direcionados nesse sentido, o significado e manejo de anormalidades pulmonares intersticiais incipientes, detectadas nos estudos de imagem, ainda não são claros. Uma vez detectado o acometimento fibrosante, é importante que o radiologista conheça aspectos característicos de determinados padrões morfológicos e reconheça elementos que possam apontar para entidades clínicas específicas. Em casos nos quais a especificidade dos achados não é suficiente para a suspeição diagnóstica, as imagens de TC servem de guia para a escolha de sítios para biópsia cirúrgica. O seguimento evolutivo é útil para a determinação de pneumopatias fibrosantes progressivas e para a detecção de complicações não relacionadas à doença de base, como infecções, exacerbação aguda e neoplasias. Ferramentas automatizadas de quantificação têm aplicabilidade clínica e devem estar acessíveis para a análise imagética no futuro próximo. Além disso, a incorporação da avaliação tomográfica a escores com parâmetros clínicos e funcionais de estadiamento do acometimento fibrosante poderá se tornar valiosa na determinação prognóstica. O conhecimento das diversas aplicabilidades clínicas do método tomográfico é fundamental aos especialistas que acompanham esses pacientes, podendo impactar positivamente sua trajetória clínica.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Axial HRCT scans with lung window settings. Note diffuse peripheral lower lobe reticular opacities (arrows in A) that are also seen on prone CT images (arrows in B), characterizing incipient interstitial lung disease.
Figure 2
Figure 2. Axial HRCT scans with lung window settings, showing fibrosing interstitial lung disease in different patients. In A, typical honeycombing, presenting as multiple layers of cysts. In B, traction bronchiectasis in an oblique coronal plane. Note the usefulness of multiplanar reconstruction in differentiating between traction bronchiectasis and honeycombing. In C, early honeycombing, presenting as a single layer of cysts. In D, note the difficulty in differentiating between honeycombing and paraseptal emphysema.
Figure 3
Figure 3. Axial HRCT scans with lung window settings, showing fibrosing interstitial lung disease in patients suspected of having idiopathic pulmonary fibrosis and presenting with different HRCT features of the usual interstitial pneumonia (UIP) pattern. In A, UIP pattern, with extensive honeycombing (arrows), peripheral distribution, and basal predominance. In B, probable UIP pattern, with peripheral reticular opacities and traction bronchiolectasis (open arrows), without honeycombing. In C, indeterminate-for-UIP pattern, with diffuse axial distribution and central involvement (arrowheads), as well as areas of ground-glass opacity, together with reticular opacities. In D, a pattern suggestive of an alternative diagnosis, with extensive areas of ground-glass opacity and a mosaic pattern of lung attenuation (open arrowheads).
Figure 4
Figure 4. Axial HRCT scans of the chest showing features related to different fibrosing diseases. In A, features suggestive of nonspecific interstitial pneumonia, with a predominance of ground-glass opacities. In B, features of pleuroparenchymal fibroelastosis confirmed by histopathology showing predominantly apical fibrosing disease with upper lobe volume loss and upward hilar retraction. In C, scan of a patient with sarcoidosis, showing fibrosing disease with an upper-lobe predominance. In D and E, scans of a patient with fibrosing lung disease caused by exposure to asbestos. Note the presence of pleural plaques (arrows in E).
Figure 5
Figure 5. Axial HRCT scans with lung window settings (in A, D, and G), coronal reconstructions (in B, E, and H), and coronal minimum intensity projection reformatted images (in C, F, and I) for three patients with fibrotic hypersensitivity pneumonitis (HP). In A, B, and C, a typical HP pattern, with diffuse interstitial fibrosis axially and relatively spared lower lung zones, as well as marked mosaic attenuation in a predominantly caudal distribution, indicating small airway disease (in C). In D, E, and F, a compatible-with-HP pattern, with predominantly peripheral, basal interstitial fibrosis and extensive honeycombing (characteristic of usual interstitial pneumonia), as well as scattered areas of mosaic attenuation, constituting evidence of small airway disease (in F). In G, H, and I, an indeterminate-for-HP pattern, with areas of ground-glass opacity, reticular opacities, and traction bronchiectasis in a diffuse axial/craniocaudal distribution, as well as no evidence of small airway disease.
Figure 6
Figure 6. Specific CT signs of fibrosis in connective tissue disease-associated fibrosing interstitial lung disease. In A and B, the “anterior upper lobe” sign (arrows) in a patient with rheumatoid arthritis. In C, the “four corners” sign (open arrows)-fibrosis focally involving the bilateral anterolateral upper lobes and posterosuperior lower lobes-in a patient with systemic sclerosis. In D, the “straight-edge” sign (arrowheads)-isolation of fibrosis to the lung bases with sharp demarcation in the craniocaudal plane. In E, the “exuberant honeycombing” sign-extensive honeycombing constituting most of the fibrotic portions of lung.
Figure 7
Figure 7. Axial HRCT scans. Initial CT scan (in A) and follow-up CT scans at six years (in B) and six and a half years (in C) in a patient with systemic sclerosis-related fibrosing interstitial lung disease. Although the follow-up scans apparently show no changes in disease progression, a comparison between the initial and follow-up scans reveals a progressive disease phenotype, underscoring the importance of comparing follow-up CT findings with initial CT findings.
Figure 8
Figure 8. Coronal reconstructions of HRCT scans showing complications of fibrosing interstitial lung disease in two patients. In A and B, scans of a patient with progressive idiopathic pulmonary fibrosis. Initial CT scan (in A) and follow-up CT scan at seven years and 10 months (in B), showing disease progression and an irregular subpleural expansile neoplastic lesion in the right lower lobe, diagnosed as adenocarcinoma (arrow in B). In C and D, scans of a patient with progressive idiopathic pulmonary fibrosis. Initial CT scan (in C) and follow-up CT scan at 15 months (in D), showing disease progression and new bilateral ground-glass opacities, characterizing acute exacerbation of idiopathic pulmonary fibrosis.

Comment in

Similar articles

Cited by

References

    1. Larsen BT, Smith ML, Elicker BM, Fernandez JM, de Morvil GAA, Pereira CAC. Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease Bringing Together Clinical, Radiologic, and Histologic Clues. Arch Pathol Lab Med. 2017;141(7):901–915. doi: 10.5858/arpa.2016-0299-SA. - DOI - PubMed
    1. Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases knowns and unknowns. Eur Respir Rev. 2019;28(151):180100–180100. doi: 10.1183/16000617.0100-2018. - DOI - PMC - PubMed
    1. American Thoracic SocietyEuropean Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 [published correction appears in Am J Respir Crit Care Med2002 Aug 1;166(3):426]. Am J Respir Crit Care Med. 2002;165(2):277–304. doi: 10.1164/ajrccm.165.2.ats01. - DOI - PubMed
    1. Travis TD, Costabel U, Hansell DM, King TE, Jr, Lynch DA, Nicholson AG. An official American Thoracic Society/European Respiratory Society statement Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748. doi: 10.1164/rccm.201308-1483ST. - DOI - PMC - PubMed
    1. Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076–180076. doi: 10.1183/16000617.0076-2018. - DOI - PMC - PubMed

MeSH terms